Dialysis Market Growth Opportunities and Forecast till 2032
The Global Dialysis Market Size was valued at USD 108.5 Billion in 2023 and is anticipated to reach USD 192.5 Billion by 2032 with a CAGR of 6.8% from 2024 to 2032.
Dialysis is a life saving process that supports the clearance of the body when the kidneys fail in their natural function of filtering excess fluids, toxins and wastes from the blood. It replaces the functions of healthy kidneys, and is vital in supporting life for patients with acute kidney disease. Dialysis is also known as renal replacement therapy in case where the kidneys can no longer perform their duties.
Kidneys in healthy condition are responsible for regulating the body with fluids and minerals while keeping wastes and toxins out of the blood. They also synthesize hormones that are important for metabolic processes in the body. However, in cases of 85-90% renal failure, the signs of body dysfunction appear to be critical. This is when dialysis comes in play which provides the support that kidneys are incapable of providing. It is very important to understand that the dialysis as a treatment is known since the 1940s and the first attempt was successful. By the 1970s it was considered a routine medical procedure for renal failure and transformed the treatment of patients with end stage renal disease. Since then, millions of people all over the world have rendered this treatment as their source of hope.
Parameter |
Dialysis Market |
Dialysis Market Size in 2023 |
US$ 108.5 Billion |
Dialysis Market Forecast By 2032 |
US$ 192.5 Billion |
Dialysis Market CAGR During 2024 – 2032 |
6.8% |
Dialysis Market Analysis Period |
2020 - 2032 |
Dialysis Market Base Year |
2023 |
Dialysis Market Forecast Data |
2024 - 2032 |
Segments Covered |
By Type, By Dialysis Type, By End User, and By Region |
Dialysis Market Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
AngioDynamics Inc., Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company (C. R. Bard, Inc.), DaVita, Diaverum Deutschland GmbH, Fresenius SE & Co. KGaA, Medtronic, Nikkiso Co. Ltd., and Nipro Corporation. |
Report Coverage |
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Dialysis Market Dynamics
An increase in the rate of incidence of chronic kidney diseases (CKDs) due to factors including aging, diabetes, high blood pressure, and change in lifestyles puts pressure on the dialysis treatment. The prevalence of CKD is rising globally, and hence the demand for kidney dialysis services and equipment also rises. CKDs are one of the common renal diseases contributing to a large part of the global kidney diseases burden; estimated to be rising to 22.2%. Prevalent data suggest that about 5.5 – 10.5 million patients with CKD need either dialysis or a kidney transplant. Furthermore, patients with CKD are at a five- to tenfold increase in mortality compared with those without CKD, excluding ESKD. The increasing incidence of CKDs and their related mortality rates are likely to shape future demand for hemodialysis (HD) and peritoneal (PD) treatments.
However, even with the increasing number of patients receiving dialysis treatment several factors may hamper market growth during the forecast period. The most notable of these are the hazards and adverse effects related to the performance of dialysis procedures. There are side effects and difficulties associated with hemodialysis, in particular. The development of vascular access for this therapy is a delicate and technical procedure, and issues connected with access can limit the use of this therapy. Dialysis affects fluid and electrolyte balance which in turn affect the heart and blood pressure putting the patient at risk. For instance, a paper that was published in BMC Nephrology in August 2020 aimed at identifying risk factors for elderly hemodialysis patients; these are cardiovascular diseases, type of vascular access, and timing of the initiation of therapy. These other chronic diseases definitely increase the mortality rate among these patients even further.
Technology such as internet of things (IoT) has been adopted in in-home care and long-term care facilities within the recent past. IoT is expected to bring about significant changes in the healthcare sector, particularly in the improvement of patient care, monitoring and efficiency. As more elderly people prefer to live independently and the global geriatric population increases, the need for IoT-based remote dialysis care and equipment, especially for home use, has grown. These devices assist the health care givers as they support the prevention, constant monitoring from a distance, and immediate treatment. Currently, there are about 2 million patients on the global stage with kidney failure, which makes it evident that there is a dire need to enhance the dialysis process through the use of IoTs. This increasing usage of IoT technology is anticipated to greatly increase its use in the remote dialysis care.
Global Dialysis Market Segment Analysis
Dialysis Market By Type
· Product
o Equipment
§ Dialysis Machines
§ Water Treatment Systems
§ Others Dialysis Equipment
o Consumables
§ Dialyzers
§ Catheters
§ Other Dialysis Consumables
§ Dialysis Drugs
· Services
As for the year 2023, the services segment has been identified to be the largest market share globally due to the growing number of renal care centers with modern technology on chronic and emergency treatments. This growth is further backed up by improvements in the delivery of quality care to the patients. Also, the transformation of service providers towards patient centric and profit seeking business models is the driving force for these services. On the other hand, the product segment is expected to record a gradual growth in the future years due to new market entrants from the regional market to meet the growing demand for modern and sophisticated devices and consumables.
Dialysis Market By Dialysis Type
· Hemodialysis (HD)
o Conventional Hemodialysis
o Short Daily Hemodialysis
o Nocturnal Hemodialysis
· Peritoneal Dialysis (PD)
o Continuous Ambulatory Peritoneal Dialysis (CAPD)
o Automated Peritoneal Dialysis (APD)
Hemodialysis segment dominated the market in terms of revenue in 2023 and is expected to continue this trend up to 2032. Lack of appropriate training for the use of peritoneal dialysis in both developed and developing world has led to reduced usage of this modality. Also, the increasing knowledge of the clinical benefits of hemodialysis such as shorter treatment schedules and popularity of AV fistulas among patients has boosted the demand. An increased prevalence of stage 3b and above CKD particularly among the elderly increases the population of patients that need hemodialysis.
However, the segment on the peritoneal dialysis is expected to experience a strong growth in the predicted period. The rise in the use of peritoneal dialysis as compare to hemodialysis in developed countries is anticipated to be the primary growth factor for this market. In addition, the increasing preference for home use peritoneal dialysis treatment is expected to drive the segment, as it is more convenient and can be prescribed by a doctor at a faster rate than others.
Dialysis Market By End User
· Dialysis Center and Hospitals
· Home Care
The dialysis center and hospitals segment was the largest segment in the global dialysis market in 2023, with a market share around 60%. This is attributable to sound reimbursement policies offered by dialysis center and hospitals and renal care facilities that have given them the nod over other products for dialysis patients. Demand has also been driven by the rapidly rising incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) that has created a huge market for dialysis services among households. In addition, the increasing cost of health care that people bear has also advanced this segment on the forward gear.
Dialysis Market Regional Analysis
North America is the largest market for dialysis equipment and services, much like a keystone supporting the foundation of innovation in renal care. This dominance could be attributed to the fact that the region boasts of well-developed healthcare systems that fully support the use of innovative dialysis technologies and best practices. The ongoing process of research and development in North America keeps on making the dials machines and procedure perfect, as a motor to make it run at its best for the patients.
The increasing incidence of CKD in this region attributed to modifiable risks including diabetes and obesity has consequently created a need for dialysis. As much as 14% of the population in the United States suffers from CKD; therefore, renal replacement therapies are becoming more important. This is so because the population of the elderly, which may be compared to a rising sea level, only increases the pressures toward the provision of these vital life prolonging therapies.
The Asia-Pacific region is expected to have a fast-growing dialysis market due to efforts targeting increasing renal care provision. A large part of investments in the region comes from the public sector mainly due to the governments’ interest in raising the development of the market and improving the availability of healthcare services. For example, in December 2016, China’s National Health and Family Planning Commission promulgated the measures for the management of hemodialysis centers across the country. This regulatory framework provides the basis for the gradual development of facilities for independent renal care to ensure unified and, at the same time, high-quality treatment.
Such policies, in conjunction with the Asia-Pacific’s rising investments in the healthcare sector and rising incidence of chronic kidney disease, are expected to drive the Asia-Pacific dialysis market in the forecast period. This is because as more countries in the region implement the same frameworks and enhance health care access, the Asia-Pacific region is expected to be a major force behind growth in the worldwide dialysis market.
Dialysis Market Leading Companies
The Dialysis market players profiled in the report is AngioDynamics Inc., Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company (C. R. Bard, Inc.), DaVita, Diaverum Deutschland GmbH, Fresenius SE & Co. KGaA, Medtronic, Nikkiso Co. Ltd., and Nipro Corporation.
Dialysis Market Regions
North America
· U.S.
· Canada
Europe
· U.K.
· Germany
· France
· Spain
· Rest of Europe
Latin America
· Brazil
· Mexico
· Rest of Latin America
Asia-Pacific
· China
· Japan
· India
· Australia
· South Korea
· Rest of Asia-Pacific
Middle East & Africa
· GCC
· South Africa
· Rest of Middle East & Africa